Les facteurs de croissance hématopoïétique ont-ils une place dans le traitement des agranulocytoses médicamenteuses?
- 31 July 2000
- journal article
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 21 (7), 580-585
- https://doi.org/10.1016/s0248-8663(00)80002-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching HospitalArchives of Internal Medicine, 1999
- Drug-induced agranulocytosis in older people. A case series of 25 patientsAge and Ageing, 1999
- Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.The American Journal of Tropical Medicine and Hygiene, 1999
- Nonchemotherapy Drug‐Induced Agranulocytosis: A Review of 118 Patients Treated with Colony‐Stimulating FactorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- A Population-Based Case-Cohort Study of Drug-Associated AgranulocytosisArchives of Internal Medicine, 1999
- Granulocyte Colony-Stimulating Factor (G-CSF) Does Not Improve Recovery from Antithyroid Drug-Induced Agranulocytosis: A Prospective StudyThyroid®, 1999
- Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Agranulocytoses aiguës médicamenteuses. Étude clinique à propos de 30 patients et évolution des étiologies sur 2 décenniesLa Revue de Médecine Interne, 1995
- The drug etiology of agranulocytosis: An update of the international agranulocytosis and aplastic anemia studyPharmacoepidemiology and Drug Safety, 1993
- Granulocyte-colony stimulating factor therapy in drug-induced agranulocytosisArchives of Internal Medicine, 1993